详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

Genetic variants in the ITGB6 gene is associated with the risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy

80| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

单位： [1]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Wuhan 430030, Hubei Province, Peoples R China [2]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Thorac Surg, Wuhan 430030, Hubei Province, Peoples R China

出处：

DOI：

ISSN：

关键词： ITGB6 Single-nucleotide polymorphism Radiation pneumonitis Lung cancer

摘要：

The alpha v beta 6 integrin is a cell surface adhesion molecule that plays critical roles in the injury and inflammation processes. We hypothesized that polymorphisms in alpha v beta 6 integrin genes (ITGAV and ITGB6) might be associated with the risk of radiation pneumonitis (RP) in lung cancer patients treated with thoracic radiation. We genotyped three potentially functional alpha v beta 6 integrin single-nucleotide polymorphisms (rs1839123 and rs4129787 in ITGAV, and rs4665162 in ITGB6) and found that the genotypes of rs4665162 single-nucleotide polymorphisms were predictors of RP development (for grade a parts per thousand yen2 RP, HR = 1.505, 95 % CI 1.069-2.119, P = 0.019; for grade a parts per thousand yen3 RP, HR = 3.006, 95 % CI 1.431-6.313, P = 0.004). Our results showed that AG/GG genotypes of ITGB6 rs4665162 gene were associated with a higher risk of RP in patients with lung cancer receiving radiotherapy and thus may serve as a reliable predictor of RP. Further studies will be needed to confirm these findings.

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2015]版：

大类 | 3 区医学

小类 | 3 区肿瘤学

最新[2025]版：

无

JCR分区：

出版当年[2014]版：

Q2 ONCOLOGY

最新[2023]版：

无

影响因子： 0 最新[2023版] 0 最新五年平均 3.611 出版当年[2014版] 3.404 出版当年五年平均 2.84 出版前一年[2013版] 2.926 出版后一年[2015版]

第一作者：

第一作者单位： [1]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Wuhan 430030, Hubei Province, Peoples R China

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Genetic variants in the plasminogen activator inhibitor-1 gene are associated with an increased risk of radiation pneumonitis in lung cancer patients [2]Identification of lung cancer oncogenes based on the mRNA expression and single nucleotide polymorphism profile data [3]Genetic variants in PI3K/AKT pathway are associated with severe radiation pneumonitis in lung cancer patients treated with radiation therapy [4]Study on the Biological Prediction Models of Radiation Pneumonitis [5]ATM Polymorphisms Predict Severe Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy [6]Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer [7]Single-nucleotide polymorphisms of TGFβ1 and ATM associated with radiation-induced pneumonitis: a prospective cohort study of thoracic cancer patients in China [8]Single-nucleotide polymorphisms of TGF beta 1 and ATM associated with radiation-induced pneumonitis: a prospective cohort study of thoracic cancer patients in China [9]Validation study of the association between genetic variant of IL4 and severe radiation pneumonitis in lung cancer patients treated with radiation therapy [10]Impact of genetic variant of HIPK2 on the risk of severe radiation pneumonitis in lung cancer patients treated with radiation therapy